CellWise outsources the wet lab and does the hard part in software: turning a high-dimensional single-cell dataset into a structured, clinician-ready read, with the quality control and population context that makes it defensible.
CellWise stays software-only. The wet lab happens at a CRO; everything that turns raw data into a clinical read happens here.
The sample is run through a single-cell licensed CRO. CellWise never touches a wet lab, so there's nothing new to build or staff.
Strict filtering removes apoptotic cells, and MAD statistics normalize the donor against a dynamic population baseline, eliminating batch effects while preserving rare signal.
Seven modules read the cleaned data: phenotyping, the peptide atlas, the aging profile, target mapping, and more.
Findings are drafted as a narrative, then reconciled against curated genomic data, population and individual, and held to a strict schema, so every statement is grounded in the data, not model guesswork. The clinician-ready report pipes into your existing portal, with surveillance between screens.
The clinical home base. Use-case assessments, immuno-metabolic phenotyping, the therapeutic target map, stress profiling, and more, all in one report.
The quantitative, visual view of the patient's raw biomarker data, shown as a population-vs-patient overview.
A filterable, gene-level interface over the patient's complete dataset, exposing the top cell populations carrying each signal.
Test a clinical hypothesis against the patient's own molecular data and re-run it in seconds.
Assay-independent surveillance across dosing phases, peptide-specific labs, and wearable trends, with no repeat sequence required.
Immune age, senescence, and the 12 hallmarks from one PBMC sample, for cell-resolved biological aging.
Re-assay a patient and see the gene-expression deltas across key biomarkers, so you see what has shifted since the last screen.
What the platform reads, ranks, and connects to.
Two things about CellWise that are easy to skim past, so we state them plainly on the page rather than only in the footer. The literature the panel was curated from is listed on the references page.
RUO means research use only. CellWise is a software-as-a-medical-device on a clearance pathway and has not been cleared or approved by the FDA. Until SaMD clearance it is for research use, it is not a diagnostic, and it is not intended to diagnose, treat, cure or prevent any disease.
CellWise is decision support for a licensed practitioner. It organizes molecular evidence and shows the reasoning behind every call, including the reasons against. Every diagnostic and treatment decision stays with the clinician and their patient.
Expression is reported against a population baseline whose version is printed on every report, and that baseline grows as samples accumulate, so reported ranges may be revised. CellWise makes no claim that a report is diagnostic, that the baseline is final, or that any clinical outcome will follow.